Insight

Jarushka Naidoo: ‘TrialGPT:’ A new chatGPT for clinical trials

Research scientist. Science laboratory, chemistry scientists and clinical lab. Medical research items, clinical science laboratories experiments. Dna, genetic test concept vector illustration

Nov 20, 2024, 00:40

Jarushka Naidoo: ‘TrialGPT:’ A new chatGPT for clinical trials

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X:

“‘TrialGPT:’ A new chatGPT for clinical trials, Nature.

– 3 steps: TrialGPT-Retrieval, TrialGPT-Matching, TrialGPT-Ranking
– Retrieval identified 90% of suitable trials
– 42% time-saving in matching a patient to a trial

Like, wow.”

Matching patients to clinical trials with large language models.

Authors: Qiao Jin, Zifeng Wang, Charalampos S. Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken-Clarke, Elisabetta Xue, Yifan Yang, Jimeng Sun and Zhiyong Lu.

Jarushka Naidoo

Dr. Jarushka Naidoo is a thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University. She currently serves as national lung cancer lead for Cancer Trials Ireland.
She serves on several international guideline panels including ASCO and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed and completed several investigator-initiated, industry-funded and cooperative group clinical trials.

She has received a number of grants including a young investigator award from the International Association for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career development award from the National Institutes of Health (NIH) KL2-program. She is the IASLC Communications Committee Chair.